Environment and Health in Contaminated Sites: The Case of Taranto, Italy
Table 4
Cancer incidence Taranto NPCS. Number of observed cases (Obs), standardized incidence ratio crude (SIR); 90% IC: 90% confidence interval; Reference SIR: macroarea South and Islands 2005–2007; Reference SIR: Taranto province excluding NPCS municipalities (TA-NPCS) 2006-2007.
Cancer site
Males
Females
OBS
SIR-macroarea South and Islands (90% CI)
SIR (TA-NPCS) (90% CI)
OBS
SIR-macro-area South and Islands (90% CI)
SIR (TA-NPCS) (90% CI)
Head and neck
52
98 (77–123)
131 (103–165)
13
96 (57–153)
134 (79–213)
Stomach
51
130 (102–164)
117 (91–148)
43
167 (127–215)
224 (171–289)
Colon and rectum
145
112 (97–129)
122 (106–140)
131
115 (99–133)
121 (104–140)
Liver
64
110 (88–135)
140 (113–172)
36
110 (82–145)
175 (130–231)
Pancreas
28
100 (71–137)
135 (96–185)
31
113 (82–153)
129 (93–174)
Lung
245
144 (129–160)
150 (135–167)
47
117 (90–149)
148 (114–189)
Skin melanoma
35
214 (158–284)
193 (143–256)
23
143 (98–203)
120 (82–170)
Mesothelioma
21
429 (287–618)
256 (172–369)
3
197 (53–509)
81 (22–209)
Breast
—
—
—
317
130 (118–143)
124 (113–136)
Prostate
204
129 (112–148)
121 (105–139)
—
—
—
Testis
12
109 (63–177)
79 (46–128)
—
—
—
Uterus, cervix
—
—
—
14
93 (56–145)
88 (53–138)
Uterus, body
—
—
—
69
134 (109–164)
188 (152–230)
Ovary
—
—
—
35
119 (88–158)
81 (60–107)
Kidney and other unspecified urinary organs
51
164 (128–207)
201 (157–254)
18
119 (77–176)
114 (74–169)
Bladder
188
141 (125–159)
136 (120–153)
23
62 (42–88)
92 (63–130)
Brain and CNS (malignant)
16
86 (54–131)
88 (55–134)
12
78 (45–126)
65 (37–105)
Thyroid
23
169 (115–239)
126 (86–179)
71
152 (124–185)
94 (76–115)
Hodgkin lymphoma
6
88 (38–174)
63 (27–124)
8
131 (65–236)
70 (35–126)
Non-Hodgkin lymphoma
42
119 (90–154)
160 (122–207)
28
88 (63–121)
143 (102–196)
Myeloma
18
140 (90–208)
135 (87–200)
15
107 (66–165)
97 (60–149)
Leukemia
30
108 (78–146)
82 (59–111)
37
164 (122–216)
103 (77–136)
All tumors excluding skin, nonmalignant brain, and CNS